Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting

Cancer Research
Sílvia BusquetsFrancisco J López-Soriano

Abstract

In cancer cachexia both cardiac and skeletal muscle suffer an important protein mobilization as a result of increased proteolysis. Administration of the beta2-agonist formoterol to both rats and mice bearing highly cachectic tumors resulted in an important reversal of the muscle-wasting process. The anti-wasting effects of the drug were based on both an activation of the rate of protein synthesis and an inhibition of the rate of muscle proteolysis. Northern blot analysis revealed that formoterol treatment resulted in a decrease in the mRNA content of ubiquitin and proteasome subunits in gastrocnemius muscles; this, together with the decreased proteasome activity observed, suggest that the main anti-proteolytic action of the drug may be based on an inhibition of the ATP-ubiquitin-dependent proteolytic system. Interestingly, the beta2-agonist was also able to diminish the increased rate of muscle apoptosis (measured as DNA laddering as well as caspase-3 activity) present in tumor-bearing animals. The present results indicate that formoterol exerted a selective, powerful protective action on heart and skeletal muscle by antagonizing the enhanced protein degradation that characterizes cancer cachexia, and it could be revealed as a ...Continue Reading

References

Jan 1, 1992·Life Sciences·Y S Kim, R D Sainz
May 1, 1992·Comparative Biochemistry and Physiology. Comparative Physiology·E T Agbenyega, A C Wareham
Nov 1, 1992·Medicinal Research Reviews·J M ArgilésF J López-Soriano
Sep 1, 1991·Agents and Actions·L R MarinariB M Weichman
Jul 1, 1989·The Biochemical Journal·Y T Yang, M A McElligott
Jul 1, 1986·The British Journal of Nutrition·P J ReedsR M Palmer
Sep 1, 1985·Bioscience Reports·N J Rothwell, M J Stock
Mar 29, 1995·International Journal of Cancer. Journal International Du Cancer·M LloveraJ M Argiles
Jan 15, 1994·Cancer Letters·C García-MartínezJ M Argilés
Oct 1, 1993·Archives of Biochemistry and Biophysics·L TessitoreF M Baccino
Jan 13, 1997·Biochemical and Biophysical Research Communications·M LloveraJ M Argilés
Sep 1, 1997·Medicinal Research Reviews·J M ArgilésF J López-Soriano
Oct 23, 1998·Molecular and Cellular Endocrinology·M LloveraJ M Argiles
Feb 19, 1999·BioTechniques·E BloughK Esser
Feb 7, 2001·Biochemical and Biophysical Research Communications·M van RoyenJ M Argilés
Jul 14, 2000·American Journal of Physiology. Endocrinology and Metabolism·A A SneddonC A Maltin
Aug 19, 2000·American Journal of Physiology. Endocrinology and Metabolism·L C NavegantesI C Kettelhut
Aug 24, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·P RajabP L Greenhaff
Feb 24, 2001·The Journal of Pharmacy and Pharmacology·N Shinkai, S Takayama
Mar 13, 2001·Biochemical and Biophysical Research Communications·C G PennerP O Hasselgren
Apr 16, 2002·Current Opinion in Clinical Nutrition and Metabolic Care·Luiz Carlos Carvalho NavegantesIsis do Carmo Kettelhut
May 16, 2002·Journal of Cellular Physiology·Sílvia BusquetsJosep M Argilés
Jul 5, 2002·Cells, Tissues, Organs·Lawrence E WineskiDouglas F Paulsen
Oct 17, 2002·Journal of Applied Physiology·Jatin G BurnistonDavid F Goldspink
Oct 22, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·James G RyallGordon S Lynch
Dec 5, 2002·The Journal of Allergy and Clinical Immunology·Donald A Mahler

❮ Previous
Next ❯

Citations

Aug 11, 2005·Pflügers Archiv : European journal of physiology·Luiz Carlos C NavegantesIsis C Kettelhut
Aug 18, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Nabila Bennani-Baiti, Declan Walsh
Jul 4, 2012·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·J M ArgilésS Busquets
Sep 24, 2013·Molecular BioSystems·Yang QuanjunZhang Junping
Apr 6, 2005·Current Opinion in Clinical Nutrition and Metabolic Care·Gerasimos S FilippatosDimitrios T Kremastinos
Sep 11, 2009·Current Opinion in Clinical Nutrition and Metabolic Care·René KoopmanGordon S Lynch
Apr 11, 2006·Annual Review of Nutrition·Vickie E Baracos
Feb 23, 2012·American Journal of Physiology. Endocrinology and Metabolism·Rebecca Berdeaux, Randi Stewart
Aug 23, 2012·Nutrition & Metabolism·Mireia OlivanJosep M Argilés
Feb 4, 2014·PloS One·Evangeline W CornwellRobert W Jackman
Aug 27, 2013·Drug Design, Development and Therapy·Giovanni MantovaniAntonio Macciò
Jan 7, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·C A GreigK C H Fearon
Jan 9, 2014·Physiological Reports·Eunhi ChoiJeffrey J Widrick
Aug 8, 2008·Current Opinion in Supportive and Palliative Care·Josep M ArgilésSílvia Busquets
Nov 6, 2007·Expert Opinion on Emerging Drugs·Josep M ArgilésSílvia Busquets
Jan 11, 2012·Expert Opinion on Emerging Drugs·Kate T Murphy, Gordon S Lynch
Feb 18, 2010·Expert Opinion on Drug Discovery·Mark Daniel Deboer
Oct 29, 2009·Expert Opinion on Emerging Drugs·Kate T Murphy, Gordon S Lynch
Nov 26, 2015·International Journal of Cancer. Journal International Du Cancer·Míriam ToledoJosep M Argilés
Feb 24, 2016·Oxidative Medicine and Cellular Longevity·Aline V BacurauPatricia C Brum
May 23, 2012·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Sílvia BusquetsJosep M Argilés
Feb 22, 2012·Drug Discovery Today·Josep M ArgilésFrancisco J López-Soriano
Jul 14, 2010·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Sílvia BusquetsJosep M Argilés
Apr 18, 2009·Archivos de bronconeumología·Martín AnguloHéctor Píriz
Oct 7, 2008·Pharmacology & Therapeutics·James G Ryall, Gordon S Lynch
Mar 11, 2008·The International Journal of Biochemistry & Cell Biology·Josep M ArgilésSílvia Busquets
Oct 2, 2007·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Gemma FusterJosep M Argilés
Aug 11, 2007·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Sílvia BusquetsJosep M Argilés
Jan 31, 2007·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Sílvia BusquetsFrancisco J López-Soriano
Jan 30, 2007·Pharmacology & Therapeutics·Gordon S LynchJames G Ryall
Dec 1, 2006·Neuromuscular Disorders : NMD·Leah J HarcourtGordon S Lynch
Jan 25, 2006·British Journal of Pharmacology·Peter MolenaarWilliam A Parsonage
Apr 9, 2011·Journal of Cachexia, Sarcopenia and Muscle·Míriam ToledoJosep M Argilés
Apr 6, 2012·Journal of Cachexia, Sarcopenia and Muscle·Kunihiro Sakuma, Akihiko Yamaguchi
Aug 24, 2012·Scandinavian Journal of Medicine & Science in Sports·V A VoltarelliP C Brum
Jan 22, 2011·Muscle & Nerve·Elisabet AmetllerFrancisco J López-Soriano
Mar 28, 2012·Journal of Cachexia, Sarcopenia and Muscle·Mary A Honors, Kimberly P Kinzig
May 9, 2012·International Journal of Experimental Pathology·Milan Holecek
Aug 18, 2005·The International Journal of Biochemistry & Cell Biology·Josep M ArgilésFrancisco J López-Soriano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis